Publication:
Imatinib mesylate decreases the cytotoxic effect of roscovitine on human glioblastoma cells in vitro and the role of midkine.

dc.contributor.authorERGUVEN, M
dc.contributor.authorBILIR, A
dc.contributor.authorYAZIHAN, N
dc.contributor.authorKORKMAZ, SAYİME
dc.contributor.authorAKTAS, E
dc.contributor.authorOVALIOGLU, C
dc.contributor.authorDundar, TOLGA TURAN
dc.contributor.authorSEYITHANOGLU, H
dc.contributor.institutionauthorKORKMAZ, SAYİME
dc.contributor.institutionauthorDÜNDAR, TOLGA TURAN
dc.contributor.institutionauthorSEYİTHANOĞLU, MEHMET HAKAN
dc.date.accessioned2019-10-05T21:03:22Z
dc.date.available2019-10-05T21:03:22Z
dc.date.issued2012-01-01
dc.description.sponsorshipİstanbul Üniversitesi
dc.identifier10.1002/clc.20258
dc.identifier.citationERGUVEN M., BILIR A., YAZIHAN N., KORKMAZ S., AKTAS E., OVALIOGLU C., Dundar T. T. , SEYITHANOGLU H., -Imatinib mesylate decreases the cytotoxic effect of roscovitine on human glioblastoma cells in vitro and the role of midkine.-, Oncology letters, cilt.3, ss.200-208, 2012
dc.identifier.doi10.3892/ol.2011.434
dc.identifier.scopus84855236250
dc.identifier.urihttps://hdl.handle.net/20.500.12645/6403
dc.identifier.wosWOS:000298124700037
dc.language.isoen
dc.titleImatinib mesylate decreases the cytotoxic effect of roscovitine on human glioblastoma cells in vitro and the role of midkine.
dc.typeArticle
dspace.entity.typePublication
local.article.journalnameClinical cardiology
local.avesis.id9f983285-5805-4493-bf77-e6fc8a97bb8d
local.avesis.response6279
local.publication.isinternational1
relation.isAuthorOfPublication5b0bc4ea-cca2-4216-832a-875f79022ba7
relation.isAuthorOfPublication9efe18e9-8f9c-4993-8717-39f7347f9791
relation.isAuthorOfPublication7dd0eaf7-a02d-4124-8747-1dca94079938
relation.isAuthorOfPublication.latestForDiscovery5b0bc4ea-cca2-4216-832a-875f79022ba7
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
OL-03-01-0200.pdf
Size:
866.62 KB
Format:
Adobe Portable Document Format
Description: